An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison images, injection guides and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Content Removal
According to TikTok, the platform has removed problematic material and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one group, a vendor posted contact information, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Item Details and Costs
Within these groups, posts display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.
Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly significant health risks”.
